Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration

Neuropathology

Volumn 34, Issue 6, 2014, Pages 555-570

  Yoshida, Mari ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Astrocytic plaque; Corticobasal degeneration; Fibril formation; Progressive supranuclear palsy; Tufted astrocyte

Indexed keywords

NANOCRYSTAL; QUANTUM DOT; TAU PROTEIN; MAPT PROTEIN, HUMAN;

ARTICLE; ASTROCYTE; AUTOPSY; BASAL GANGLION; BIOACCUMULATION; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; CYTOPLASM; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; HUMAN; IMMUNOELECTRON MICROSCOPY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; SYNAPTIC MEMBRANE; TAUOPATHY; AGED; BRAIN CORTEX; CELL INCLUSION; METABOLISM; MIDDLE AGED; NERVE DEGENERATION; PATHOLOGY; ULTRASTRUCTURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASTROCYTES; BASAL GANGLIA; CEREBRAL CORTEX; HUMANS; INCLUSION BODIES; MIDDLE AGED; NERVE DEGENERATION; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 84915817214     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12143     Document Type: Article

References (50)

1. Steele J, Richardson C, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964; 10: 333-359.
2. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of the late adult life. Trans Am Neurol Assoc 1967; 92: 23-26.
3. Hauw JJ, Daniel SE, Dickson D etal. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-2019.
4. Nukina N, Quan Y, Nakano I, Otomo E. Widespread tau abnormality in a case of cortico-basal degeneration. (In Japanese with English abstract. Rinsho Shinkeigaku 1992; 32: 1093-1101.
5. Dickson DW, Bergeron C, Chin SS etal. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935-946.
6. Komori T, Arai N, Oda M etal. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 1998; 96: 401-408.
7. Williams DR, de Silva R, Paviour DC etal. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 1247-1258.
8. Williams DR, Holton JL, Strand C, Pittman A, de Silva R etal. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007; 130: 1566-1576.
9. Williams DR, Holton JL, Strand K etal. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007; 22: 2235-2241.
10. Mochizuki A, Ueda Y, Komatsuzaki Y, Tsuchiya K, Arai T, Shoji S. Progressive supranuclear palsy presenting with primary progressive aphasia - Clinicopathological report of an autopsy case. Acta Neuropathol 2003; 105: 610-614.
11. Josephs KA, Boeve BF, Duffy JR etal. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 2005; 11: 283-296.
12. Kanazawa M, Shimohata T, Toyoshima Y etal. Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 2009; 24: 1312-1318.
13. Iwasaki Y, Mori K, Ito M, Tatsumi S, Mimuro M, Yoshida M. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement. Neuropathology 2013; 33: 561-567.
14. Litvan I, Hauw JJ, Bartko JJ etal. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105.
15. Kato T, Hirano A, Weinberg MN, Jacobs AK. Spinalcord lesion in progressive supranuclear palsy: somenew observations. Acta Neuropathol 1986; 71: 11-14.
16. Kikuchi H, Doh-ura K, Kira J, Iwai T. Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy. Acta Neuropathol 1999; 97: 577-584.
17. Iwasaki Y, Yoshida M, Hashizume Y, Hattori M, Aiba I, Sobue G. Widespread spinal cord involvement in progressive supranuclear palsy. Neuropathology 2007; 27: 331-340.
18. Arai N, Oda M. A variety of glial pathological structures by the modified Gallyas-Braak method. Neuropathology 1996; 16: 133-138.
19. Hauw JJ, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 1990; 119: 182-186.
20. Yamada T, McGeer PL, McGeer EG. Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 1992; 135: 99-102.
21. Yamada T, Calne DB, Akiyama H, McGeer EG, McGeer PL. Further observations on tau-positive glia in the brains with progressive supranuclear palsy. Acta Neuropathol 1993; 85: 308-315.
22. Nishimura T, Ikeda K, Akiyama H etal. Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Neurosci Lett 1995; 201: 123-126.
23. Nishimura M, Namba Y, Ikeda K, Oda M. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett 1992; 143: 35-38.
24. Arima K. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 2006; 26: 475-483.
25. Iwasaki Y, Yoshida M, Hattori M etal. Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy. Acta Neuropathol 2004; 108: 399-405.
26. Yoshida M. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 2006; 26: 457-470.
27. Boeve BF, Maraganore DM, Parisi JE etal. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795-800.
28. Togo T, Dickson DW. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol 2002; 104: 398-402.
29. Ahmed Z, Bigio H, Budka H etal. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol 2013; 126: 537-544.
30. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989; 112: 1171-1192.
31. Riley DE, Lang AE, Lewis A etal. Cortical-basal ganglionic degeneration. Neurology 1990; 40: 1203-1212.
32. Josephs KA, Tang-Wai DF, Edland SD etal. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004; 61: 1881-1884.
33. Mizuno T, Shiga K, Nakata Y etal. Discrepancy between clinical and pathological diagnoses of CBD and PSP. J Neurol 2005; 252: 687-697.
34. Murray R, Neumann M, Forman MS etal. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 2007; 68: 1274-1283.
35. Ling H, O'Sullivan SS, Holton JL etal. Does corticobasal degeneration exist ? A clinicopathological re-evaluation. Brain 2010; 133: 2045-2057.
36. Armstrong MJ, Litvan I, Lang AE etal. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 496-503.
37. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995; 146: 1388-1396.
38. Heines MA, Guyot-Sionnest P. Synthesis and characterization of strongly luminsecing ZnS-capped CdSe nanocrystals. J Phys Chem 1996; 100: 468-471.
39. Giepmans BN, Deerinck TJ, Smarr BL, Jones YZ, Ellisman MH. Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots. Nat Methods 2005; 2: 743-749.
40. Uematsu M, Adachi E, Nakamura A, Tsuchiya K, Uchihara T. Atomic identification of fluorescent Q-dots on tau-positive fibrils in 3D-reconstructed Pick bodies. Am J Pathol 2012; 180: 1394-1397.
41. Hirano A. A guide to neuropathology. IGAKU-SHOIN Tokyo, 1981.
42. Hattori M, Hashizume Y, Yoshida M etal. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol 2003; 106: 143-149.
43. Hattori M, Yoshida M, Ojika K, Yuasa H, Mitake S etal. An autopsy case of corticobasal degeneration without prominent cortical pathology - an imitator of progressive supranuclear palsy (in Japanese with English astract). Rinsho Shinkeigaku 2000; 40: 372-377.
44. Katsuse O, Iseki E, Arai T etal. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 2003; 106: 251-260.
45. Tan CF, Piao YS, Kakita A etal. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration? Acta Neuropathol 2005; 109: 329-338.
46. Tuite PJ, Clark HB, Bergeron C etal. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol 2005; 62: 1453-1457.
47. Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K. Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol 1994; 88: 379-383.
48. Ikeda K. Basic pathology of corticobasal degeneration. Neuropathology 1997; 17: 127-133.
49. Arai T, Ikeda K, Akiyama H etal. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 2004; 55: 72-79.
50. Shibuya K, Yagishita S, Nakamura A, Uchihara T. Perivascular orientation of astrocytic plaques and tuft-shaped astrocytes. Brain Res 2011; 1404: 50-54.